ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,180Medicare Part D Prescriptions Filled, Including Refills

Rank: 55 out of 387

$884K Total Retail Price of All Prescriptions

Rank: 43 out of 387

412 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
35% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 412 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 412 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 11,205 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
LEVOTHYROXINE SODIUM 424 363 1 2
OMEPRAZOLE 410 337 2 4
LISINOPRIL 378 298 3 3
TRAMADOL HCL 362 296 4 14
GABAPENTIN 351 282 5 10
PRAVASTATIN SODIUM 338 306 6 15
AMLODIPINE BESYLATE 337 299 7 6
SIMVASTATIN 314 310 8 5
POTASSIUM CHLORIDE 308 269 9 9
METOPROLOL SUCCINATE 284 270 10 18
MELOXICAM 283 240 11 22
GLIMEPIRIDE 276 226 12 50
FUROSEMIDE 274 222 13 7
CITALOPRAM HBR 247 217 14 19
LOSARTAN POTASSIUM 239 217 15 24
DONEPEZIL HCL 180 180 16 27
HYDROCODONE-ACETAMINOPHEN 173 123 S3 17 1
WARFARIN SODIUM 170 157 18 17
CRESTOR 170 128 18 34
DIOVAN HCT 163 141 20 74
METFORMIN HCL 143 115 21 8
METOPROLOL TARTRATE 138 129 22 11
HYDROCHLOROTHIAZIDE 133 115 23 12
TRIAMTERENE-HCTZ 129 99 24 55
ATORVASTATIN CALCIUM 128 118 25 13
CLOPIDOGREL 126 112 26 25
JANUVIA 122 83 27 60
ADVAIR DISKUS 120 108 28 41
METFORMIN HCL ER 118 84 29 81
ACTOS 113 101 30 99
DIGOXIN 111 111 31 40
TAMSULOSIN HCL 110 110 32 32
NEXIUM 109 74 33 26
LANTUS 108 77 34 51
DIOVAN 102 90 35 33
NAMENDA 101 101 36 35
ALLOPURINOL 99 70 37 28
PLAVIX 98 90 38 39
LOSARTAN-HYDROCHLOROTHIAZIDE 95 92 39 65
ATENOLOL 92 83 40 20
CYCLOBENZAPRINE HCL 91 39 R 41 42
BENAZEPRIL HCL 90 90 42 86
CARVEDILOL 88 83 43 21
AMLODIPINE BESYLATE-BENAZEPRIL 83 83 44 54
ZOLPIDEM TARTRATE 83 65 44 16
ZETIA 82 66 46 96
CLONIDINE HCL 82 59 46 38
VENLAFAXINE HCL ER 80 64 48 97
CYMBALTA 75 56 49 44
ALENDRONATE SODIUM 73 73 50 31
METHYLPREDNISOLONE 72 66 51 101
PROAIR HFA 69 40 52 47
SERTRALINE HCL 67 52 53 23
CELEBREX 66 51 54 72
PANTOPRAZOLE SODIUM 66 55 54 48
ROPINIROLE HCL 66 49 54 91
FLUOXETINE HCL 64 40 57 46
LISINOPRIL-HYDROCHLOROTHIAZIDE 62 45 58 30
LYRICA 58 51 59 66
PIOGLITAZONE HCL 56 50 R 60 305
DILTIAZEM ER 56 52 60 139
NABUMETONE 56 45 60 117
BUSPIRONE HCL 56 56 60 121
PROPRANOLOL HCL 55 55 64 100
AZITHROMYCIN 53 45 65 49
EXFORGE 53 53 65 157
RANITIDINE HCL 53 44 65 45
FAMOTIDINE 53 53 65 78
FLUTICASONE PROPIONATE 52 34 69 29
TRICOR 51 30 70 145
AMITRIPTYLINE HCL 50 36 R 71 62
TRAZODONE HCL 50 35 71 37
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 19, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.